Passage Bio (NASDAQ:PASG) rose 6.99% on June 23, 2026, closing at $6.12 after a $0.40 per-share move. The session’s advance came as strategic alternatives keep the gene-therapy stock in focus, based on the available company disclosures and trading context.
Sadot Group (NASDAQ:SDOT) rose 9.14% on June 23, 2026, closing at $10.10 after a $0.85 per-share move. The session’s advance came as a reverse split and acquisition activity sustain volatility, based on the available company disclosures and trading context.
HeartSciences (NASDAQ:HSCS) rose 55.37% on June 23, 2026, closing at $2.75 after a $0.98 per-share move. The session’s advance came as the Fortitude Mining merger drove a digital-asset pivot, based on the available company disclosures and trading context.
Maase (NASDAQ:MAAS) rose 18.99% on June 23, 2026, closing at $21.24 after a $3.39 per-share move. The session’s advance came as low-float post-listing momentum extended the rally, based on the available company disclosures and trading context.
Quantinuum (NASDAQ:QNT) rose 13.46% on June 23, 2026, closing at $77.46 after a $9.19 per-share move. The session’s advance came as US quantum orders extend post-IPO momentum, based on the available company disclosures and trading context.
Lakewood-Amedex (NASDAQ:LABT) rose 8.77% on June 23, 2026, closing at $3.97 after a $0.32 per-share move. The session’s advance came as post-listing demand lifted the antibiotic developer, based on the available company disclosures and trading context.
Phoenix Asia Holdings (NASDAQ:PHOE) rose 11.21% on June 23, 2026, closing at $17.96 after a $1.81 per-share move. The session’s advance came as thin-float momentum lifted the newly listed holding company, based on the available company disclosures and trading context.
Hang Feng Technology Innovation (NASDAQ:FOFO) rose 32.27% on June 23, 2026, closing at $3.73 after a $0.91 per-share move. The session’s advance came as newly listed micro-cap attracted speculative momentum, based on the available company disclosures and trading context.
When institutional and retail investors discuss the Nasdaq composite, the conversation gravitates naturally toward capital appreciation, disruptive innovation, and the concentrated volatility of large-cap technology. What receives considerably less attention is the exchange's parallel identity as a serious venue for income-oriented capital allocation.
Mergers and acquisitions activity worldwide is moving toward a milestone $4 trillion in deal value for 2026. Reaching that level would mark the most robust year for M&A since 2021, as firms pursue growth‑oriented transactions while macro‑economic conditions show signs of stabilising. This momentum …